- Home
- WIMI vs MNOV Comparison
WIMI vs MNOV Comparison
Compare WIMI & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIMI
- MNOV
- Stock Information
- Founded
- WIMI 2015
- MNOV 2000
- Country
- WIMI China
- MNOV United States
- Employees
- WIMI N/A
- MNOV N/A
- Industry
- WIMI Computer Software: Prepackaged Software
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- WIMI Technology
- MNOV Health Care
- Exchange
- WIMI Nasdaq
- MNOV Nasdaq
- Market Cap
- WIMI 94.3M
- MNOV 76.0M
- IPO Year
- WIMI 2020
- MNOV 2005
- Fundamental
- Price
- WIMI $5.06
- MNOV $1.56
- Analyst Decision
- WIMI
- MNOV Strong Buy
- Analyst Count
- WIMI 0
- MNOV 1
- Target Price
- WIMI N/A
- MNOV $9.00
- AVG Volume (30 Days)
- WIMI 7.6M
- MNOV 16.0K
- Earning Date
- WIMI 01-01-0001
- MNOV 05-08-2025
- Dividend Yield
- WIMI N/A
- MNOV N/A
- EPS Growth
- WIMI N/A
- MNOV N/A
- EPS
- WIMI N/A
- MNOV N/A
- Revenue
- WIMI $84,137,968.00
- MNOV N/A
- Revenue This Year
- WIMI N/A
- MNOV N/A
- Revenue Next Year
- WIMI N/A
- MNOV N/A
- P/E Ratio
- WIMI N/A
- MNOV N/A
- Revenue Growth
- WIMI 19.25
- MNOV N/A
- 52 Week Low
- WIMI $0.27
- MNOV $1.12
- 52 Week High
- WIMI $2.92
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- WIMI 42.53
- MNOV 60.40
- Support Level
- WIMI $3.82
- MNOV $1.43
- Resistance Level
- WIMI $5.85
- MNOV $1.52
- Average True Range (ATR)
- WIMI 1.15
- MNOV 0.09
- MACD
- WIMI 0.01
- MNOV 0.03
- Stochastic Oscillator
- WIMI 36.05
- MNOV 100.00
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings primarily consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.